Physician profile
Robert Land
NPI 1972148708
$4,810.92
in general payments reported to CMS, 2019-2025
45 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,693 · 2022: $1,245 · 2023: $469 · 2024: $299 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $846.17 | 2021-2025 | |
| Glaxosmithkline, LLC. | $367.94 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $333.76 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Amarin Pharma, INC. | $278.95 | 2021-2022 | |
| Lilly USA, LLC | $244.28 | 2021-2023 | Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.38 | 2021-2025 | Jardiance, Synjardy |
| Novo Nordisk INC | $218.56 | 2021-2025 | Ozempic, Rybelsus |
| Mannkind Corporation | $178.31 | 2021 | |
| Pfizer INC. | $176.16 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $147.90 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $140.12 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $131.76 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.00 | 2021-2022 | |
| Insulet Corporation | $101.93 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $95.94 | 2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Land listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.